ARTICLE | Company News
Clinigen Group, Neuraltus sales and marketing update
October 5, 2015 7:00 AM UTC
The companies launched a managed access program in Europe for Neuraltus’ NP001 to treat amyotrophic lateral sclerosis. By year end, Neuraltus plans to start a Phase II trial of the small molecule reg...